DaVita Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
DaVita Inc Stock Forecast and Price Target
DaVita Inc's most recent price target of $133.00 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $133.00. If this prediction is correct, DaVita Inc's stock could rise by 4.05 percent from its current trading price. The potential increase for the stock is $133.00 per share, with a possible range of $119.80 to $145.00. If you're looking to buy DaVita Inc stock, you may also want to check out its rivals.
4.05% Upside
DaVita Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, DaVita Inc's Price has fallen from $81.24 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $132.83 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OPCH Stock Forecast | Option Care Health | Buy |
14
|
$31.08 | Buy/Sell | $0.00 | 24.84% |
| SGRY Stock Forecast | Surgery Partners | Buy |
13
|
$23.83 | Buy/Sell | $43.20 | 80.44% |
| PGNY Stock Forecast | Progyny | Buy |
16
|
$32.70 | Buy/Sell | $46.44 | 43.73% |
| TDOC Stock Forecast | Teladoc Health | Hold |
7
|
$12.98 | Buy/Sell | $23.31 | 39.83% |
| BEAT Stock Forecast | BioTelemetry | - |
16
|
$2.27 | Buy/Sell | $72.00 | -100.00% |
DaVita Inc Revenue Forecast for 2023 - 2025 - 2030
DaVita Inc's Revenue has seen impressive growth In the last three years, rising from $11.55B to $12.14B – a growth of 5.10%. In the next year, analysts believe that Revenue will reach $13.11B – an increase of 8.00%. For the next seven years, the forecast is for Revenue to grow by 35.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AMEH Stock Forecast | Apollo Medical Holdings | Buy |
14
|
$37.22 | Buy/Sell | $47.50 | 41.05% |
| TVTY Stock Forecast | Tivity Health | Hold |
13
|
$32.50 | Buy/Sell | $27.00 | -100.00% |
| VMD Stock Forecast | Viemed Healthcare | Buy |
16
|
C$7.88 | Buy/Sell | C$13.69 | 90.36% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DLHC Stock Forecast | DLH Holdings | Buy |
16
|
$11.27 | Buy/Sell | $21.00 | 86.34% |
| ARA Stock Forecast | American Renal Associates Hold... | - |
14
|
$0.55 | Buy/Sell | $10.00 | -100.00% |
| QIPT Stock Forecast | Quipt Home Medical | Buy |
13
|
C$4.74 | Buy/Sell | C$13.39 | 166.46% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CCEL Stock Forecast | Cryo-Cell International | Outperform |
14
|
$7.50 | Buy/Sell | $10.00 | 20.00% |
| AMS Stock Forecast | American Shared Hospital Servi... |
0
|
$2.99 | Buy/Sell | $0.00 | 60.54% | |
| PFHO Stock Forecast | Pacific Health Care Organizati... | - |
0
|
$0.73 | Buy/Sell | $0.00 | -100.00% |
DaVita Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, DaVita Inc's EBITDA has decreased from $2.35B to $2.35B – a 0.13% drop. Analysts predict that DaVita Inc's EBITDA will increase in the upcoming year, reaching $2.73B. This would represent an increase of 16.39%. Over the next seven years, experts predict that DaVita Inc's EBITDA will grow at a rate of 53.68%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OSCI Stock Forecast | Osceola Gold | - |
0
|
$0.03 | Buy/Sell | $0.00 | -100.00% |
| SPIN Stock Forecast | Spine Injury Solutions | - |
-3
|
$0.15 | Buy/Sell | $0.00 | -100.00% |
| IONM Stock Forecast | Assure Holdings | - |
7
|
$0.23 | Buy/Sell | $7.83 | -100.00% |
DaVita Inc EBIT Forecast for 2023 - 2025 - 2030
DaVita Inc's EBIT has decreased by 6.86% In the last three years, from $1.72B to $1.60B. In the next year, analysts believe that EBIT will reach $2.02B – an increase of 26.11%. For the next seven years, the forecast is forEBIT to grow by 66.15%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MHCC Stock Forecast | Millennium Healthcare | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| NWPN Stock Forecast | The Now | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| DFHL Stock Forecast | Dong Fang Hui Le | - |
0
|
$4.50 | Buy/Sell | $0.00 | -100.00% |
DaVita Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, DaVita Inc's EPS has fallen from $7.26 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $11.87 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CBDS Stock Forecast | Cannabis Sativa | - |
6
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| SMAS Stock Forecast | Somatic Systems | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| UCBB Stock Forecast | US-China Biomedical Technology | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
.jpg)